Trial Profile
Fosrenol for Enhancing Dietary Protein Intake in Hypoalbuminemic Dialysis Patients (FrEDI) Study: An Investigator Initiated Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Lanthanum carbonate (Primary)
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- Acronyms FrEDI
- 25 Nov 2016 New trial record